3D Ultrasound Visualization for Improved Care

Revolutionizing musculoskeletal ultrasound to deliver effective, efficient, and comprehensive patient care.

Introducing MSK NovaVue

With a global aging population, musculoskeletal conditions and injuries are on the rise, pointing to a dire need for accessible and effective point-of-care imaging to accomodate for the rising number of patients.

*not licensed for sale before Health Canada and FDA approval

Diagnosis

3DUS allows for improved:

  • Quantification of inflammation (e.g., synovitis)
  • Detection of disease extent (e.g., arthritis)
  • Detection of injury/trauma (e.g., tears, cysts, edema)
  • Detection of blood flow (e.g., angiogenesis)

Monitoring

3DUS allows for:

  • Precise measurement of treatment effectiveness
  • Monitoring of progression of disease
  • Monitoring of treatment response

Clinical Trials

Precise measurements using 3DUS allows for:

  • Reducing number of subjects
  • Shortening length of trial
  • Detection of small effects

Our Collaborators

Our Applications

Our cutting-edge technology backed by academic research at Robarts Research Institute, one of Canada’s leading research centers in the development and implementation of technologies in advanced imaging.

Visualizing and quantifying joint synovial volume

(du Toit et al., 2023)

3D ultrasound to visualize synovial blood flow in arthritic patients

(Hutter et al., 2023)

Address:

Bionext Incubator

Robarts Research Institute

Western University

1151 Richmond Street, London ON, N6A 5B7

If you have any questions, let us know.

novasonix.healthcare@gmail.com

Follow us

© 2023 NovaSonix Healthcare Inc.